glp-1 and afib Effects of Glucagon-Like Peptide-1 Receptor Agonists on Atrial Fibrillation Recurrence After Catheter Ablation GLP-1 receptor agonists and myocardial

For allergens, see ingredients in uppercase

Sci Rep 5:16702

Y.XueH.et al (2019)

Research domains include sleep architecture analysis, circadian rhythm studies, and stress-response regulation

Obesity: They are used as an adjunct to a reduced-calorie diet and increased physical activity to help promote weight loss in adults with a body mass index (BMI) of 30 or higher, or in adults with a BMI of 27 or higher who have at least one weight-related comorbidity, such as high blood pressure, type 2 diabetes, or high cholesterol

In Phase 2 trials, participants achieved up to 24.2% body weight loss at 48 weeks, the highest ever recorded for an obesity medication